The first phase 3 randomised clinical trial of an investigational mRNAnorovirusvaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy ...
2 mRNA-1403 is an mRNAvaccine in development to prevent moderate to severe acute gastroenteritis caused by norovirus. The vaccine candidate is a trivalent formulation containing mRNA that ...
Some results have been hidden because they may be inaccessible to you